Indefinite Delivery Contract SPE2DR25D9356

The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical products and medical supplies to support the medical supply needs of military health facilities worldwide. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

This IDC is part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, a $30.3 billion unrestricted and fully competitive acquisition to establish multiple regional prime vendor contracts for worldwide pharmaceutical support to the Department of Defense (DoD), United States Coast Guard, and other government agencies. The PPV-G GEN V contracts will have a 30-month base period and three 30-month option periods, and will be awarded on a lowest price technically acceptable basis, with the intention to make at least three different contractor awards across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items to ensure resiliency and access to vital pharmaceuticals.